1XL0

Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2005-03-15	Initial release
1.1	2008-04-30		Version format compliance
1.2	2011-07-13		Derived calculations, Version format compliance
1.3	2020-07-29	Remediation / Carbohydrate remediation	Data collection, Derived calculations, Structure summary	chem_comp, diffrn_source, entity, pdbx_entity_nonpoly, struct_conn, struct_site, struct_site_gen	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.